Michael Robin Witt
Amministratore Delegato presso GABATHER AB
Provenienza dei contatti di primo grado di Michael Robin Witt
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 9 | |
Axcentua Pharmaceuticals AB
 Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden.
4
| Private Company | Pharmaceuticals: Major | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Michael Robin Witt tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| TAURUS ENERGY AB | Oil & Gas Production | Director/Board Member | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Doctorate Degree Corporate Officer/Principal | |
| University of Cambridge | College/University | Doctorate Degree | |
| OREXO AB | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Stockholm School of Economics | College/University | Masters Business Admin | |
| University of Uppsala | College/University | Doctorate Degree | |
| University of Stockholm | College/University | Corporate Officer/Principal Graduate Degree | |
| University of Lund | College/University | Doctorate Degree Corporate Officer/Principal | |
| University of Bonn | College/University | Doctorate Degree | |
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Investment Managers | Private Equity Investor | |
Respiratorius AB
 Respiratorius AB Pharmaceuticals: MajorHealth Technology Respiratorius AB engages in the development of drug candidates for Chronic Obstructive Pulmonary Disease, asthma, and cancer. The company was founded by Lars Christer Fedrik Fåhraeus and Staffan Skogwall in 1999 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Oncorel AB
 Oncorel AB Miscellaneous Commercial ServicesCommercial Services Oncorel AB provides medical research services. It pertains to develop anti-cancer treatment. The company was founded in 2009 and is headquartered in Lund, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
Novartis Sverige AB
 Novartis Sverige AB Pharmaceuticals: MajorHealth Technology Novartis Sverige AB trades pharmaceutical products. It offers products for the treatment of ADHD, multiple sclerosis, urticaria, allergic asthma, psoriasis, chronic obstructive pulmonary disorder, migraine, blood diseases, eye disorder, and other diseases. The company is headquartered in Kista, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Shaanxi University of Traditional Chinese Medicine | College/University | Corporate Officer/Principal | |
Forskarpatent i Syd AB
 Forskarpatent i Syd AB Miscellaneous Commercial ServicesCommercial Services Forskarpatent i Syd AB specialises in the commercialisation, through licensing or new venture spinouts, of patentable inventions emanating mainly from Swedish universities. It holds a portfolio of projects in the format of shares in spinouts, partnered (licensed) and still unpartnered assets. It is involves in projects in pharmaceutical, technology, and food categories. The firm is categorized under patent agency operations. The company was founded on January 18, 1996 and is headquartered in Lund, Sweden. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Cardio Vax LLC | Director/Board Member | ||
| Jakten 7 AB | Director/Board Member | ||
PheroNet AB
 PheroNet AB Chemicals: AgriculturalProcess Industries PheroNet AB provides lures for insect monitoring. It offers insect pheromones for pest management, pheromone traps to detect harmful insect species in a crop, and synthetic pheromones for mating disruptions. Its products include adoxophyes orana, anarsia lineatella, bonagota cranaodes, cydia pomonella, cydia splendana, eupoecilia ambiguella, grapholita funebrana, grapholita lobarzewskii grapholita molesta, lobesia botrana, pammene rhediella, pandemis heparana, sparganothis pilleriana and spilonota ocellana. The company is headquartered in Alnarp, Sweden. | Chemicals: Agricultural | Chief Executive Officer | |
Laccure AB
 Laccure AB Pharmaceuticals: GenericHealth Technology Laccure AB develops products for the treatment and prevention of bacterial vaginosis. It is a pharmaceutical company that offers non-prescription vaginal tablet for women. The firm's product is based on a proprietary substance that releases lactic acid over an extended period of time to decrease elevated vaginal potential of hydrogen. It engages in research, development, training, marketing, and sales in the field of skin care and hygiene activities. The company was founded by Olov Arvid Sterner in 2007 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Generic | Director/Board Member Founder | |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Founder | |
Oncorena AB
 Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| Stockholms läns Landsting | General Government | Corporate Officer/Principal | |
| Accequa AB | Chairman Founder | ||
Glactone Pharma AB
 Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Glactone Pharma AB engages in the development of pipeline of novel signal transducer and activator of transcription 3 inhibitors. Its pipeline is used for immuno-oncology and for the treatment of drug resistant cancers, including castration resistant prostate cancer. The company was founded by Anders Sigvard Bjartell, Rebecka Hellsten, Martin Johansson, Eduardo Munoz, and Olov Arvid Sterner in 2012 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Founder | |
| Glactone Pharma Development AB | Director/Board Member | ||
Oncorena Holding AB
 Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| COMBIGENE AB | Pharmaceuticals: Major | Chairman | |
Aptahem AB
 Aptahem AB Pharmaceuticals: MajorHealth Technology Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden. | Pharmaceuticals: Major | Founder Chief Executive Officer | |
| Portendo Standoff Detection AB | Founder | ||
| Ceratmo AB | Director/Board Member | ||
| CYXONE AB | Pharmaceuticals: Major | Founder Director/Board Member | |
Science Village Scandinavia AB
 Science Village Scandinavia AB Real Estate DevelopmentFinance Science Village Scandinavia AB rents commercial properties. The private company is based in Lund, Sweden. | Real Estate Development | Director/Board Member | |
Gedea Biotech AB
 Gedea Biotech AB Miscellaneous Commercial ServicesCommercial Services Gedea Biotech AB provides drugs for the treatment of bacterial and fungal diseases. It develops an antibiotic-free treatment for vaginal fungal infections. The company was founded by Olov Arvid Sterner, Ingrid Helena Strevens, Ulf Christian Ellervik, and Sophie Margareta Manner and is headquartered in Lund, Sweden. | Miscellaneous Commercial Services | Founder | |
| Swedish Confederation of Professional Associations | Corporate Officer/Principal | ||
Stelmast AB
 Stelmast AB TruckingTransportation Stelmast AB provides road transportation services. The private company is based in Helsingborg, Sweden. | Trucking | Director/Board Member | |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Founder | |
Sinfonia Biotherapeutics AB
 Sinfonia Biotherapeutics AB BiotechnologyHealth Technology Sinfonia Biotherapeutics AB is a clinical stage company based in Huddinge, Sweden. The Swedish company develops biologics for the treatment of neuropathic pain. | Biotechnology | Director of Finance/CFO | |
| ECTIN RESEARCH AB | Biotechnology | Director of Finance/CFO | |
| Galecto Biotech AB | Founder Founder | ||
| Accequa GmbH | Director/Board Member Director/Board Member | ||
| Selcis Biopharma AB | Chairman | ||
| Gabather Finans AB | Director/Board Member | ||
| Aptahem Finans AB | Founder | ||
| Serstech Förvaltning AB | Founder | ||
| Mikeoo Holding AB | Founder | ||
| Holy Plantmedix AB | Founder | ||
Melius Pharma AB
 Melius Pharma AB Pharmaceuticals: MajorHealth Technology Melius Pharma AB is a Swedish clinical stage pharmaceutical company that develops new treatments for chronic cough in idiopathic pulmonary fibrosis (IPF) patients. The company is based in Lund, Sweden and is privately owned, benefiting from the support of two of Sweden's most prominent professional life science investors who bring expertise to develop the company. IPF is a chronic, progressive lung inflammation characterized by fibrosis and disruption of normal lung architecture. Melius Pharma has developed ME-015, which stabilizes ion channels in the neuronal endings in the lungs that mediate cough. ME-015 is presumed to have an acute effect and is a solution for chronic cough, which is one of the major symptoms experienced by 80%% of IPF patients. | Pharmaceuticals: Major | Director of Finance/CFO | |
| SENSIDOSE AB | Electronic Equipment/Instruments | Director/Board Member Director of Finance/CFO | |
| BIOEXTRAX AB | Biotechnology | Director of Finance/CFO |
Statistiche
Distribuzione geografica
| Svezia | 45 |
| Regno Unito | 2 |
| Germania | 2 |
| Cina | 2 |
| Stati Uniti | 2 |
Settori
| Health Technology | 17 |
| Consumer Services | 9 |
| Commercial Services | 5 |
| Finance | 3 |
| Energy Minerals | 2 |
Posizioni
| Director/Board Member | 59 |
| Founder | 26 |
| Corporate Officer/Principal | 22 |
| Chairman | 9 |
| Doctorate Degree | 8 |
Contatti più connessi
- Borsa valori
- Insiders
- Michael Robin Witt
- Connessioni Società
